Search
forResearch 8 of 203
- The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- A Window into Mammalian Basement Membrane Development: Insights from the<i>mTurq2-Col4a1</i>Mouse Model
- 014 Tyrosine Kinase 2 Inhibition Ameliorates the Phenotype of Lesional Alopecia Areata Scalp Skin Ex Vivo, and Reverses the Induction of Human Alopecia Areata in a Humanized Mouse Model
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- 700 Tyrosine kinase 2 inhibition rescues hair follicles from IL-12–mediated immune privilege collapse and reverses the induction of human alopecia areata in a humanized mouse model
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →